1. Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
- Author
-
Heydarzadeh S, Moshtaghie AA, Daneshpour M, and Hedayati M
- Subjects
- Humans, Rutin pharmacology, Cell Line, Tumor, Cell Survival drug effects, Tumor Cells, Cultured, Glucose Transporter Type 1 metabolism, Glucose Transporter Type 1 genetics, Cell Proliferation drug effects, Glucose metabolism, Thyroid Carcinoma, Anaplastic drug therapy, Thyroid Carcinoma, Anaplastic pathology, Thyroid Carcinoma, Anaplastic metabolism, Thyroid Neoplasms metabolism, Thyroid Neoplasms pathology, Thyroid Neoplasms drug therapy, Iodine pharmacology, Iodine metabolism
- Abstract
Aims and Background: The alternative manner of iodide and glucose uptake found in different types of thyroid cancer, referred to flip-flop. ATC cells indicate low iodide uptake and high glucose uptake, which lack the morphology and genetic characteristics of well-differentiated tumors and become increasingly invasive. Importance placed on the discovery of innovative multi-targeted medicines to suppress the dysregulated signaling in cancer. In this research, we aimed to clarify molecular mechanism of Rutin as a phytomedicine on anaplastic thyroid cancer cell line based on iodide and glucose uptake., Material Methods: The MTT test was employed to test cell viability. Iodide uptake assay was performed using a spectrophotometric assay to determine iodide uptake in SW1736 cells based on Sandell-Kolthoff reaction. For glucose uptake detection, ''GOD-PAP'' enzymatic colorimetric assay was applied to measure the direct glucose levels inside of the cells. Determination of NIS, GLUT1 and 3 mRNA expression in SW1736 cells was performed by qRT-PCR. Determination of NIS, GLUT1 and 3 protein levels in SW1736 cells was performed by western blotting., Results: According to our results, Rutin inhibited the viability of SW1736 cells in a time- and dose-dependent manner. Quantitative Real-time RT-PCR analysis exposed that NIS mRNA levels were increased in Rutin treated group compared to the control group. Accordingly, western blot showed high expression of NIS protein and low expression of GLUT 1 and 3 in Rutin treated SW1736 cell line. Rutin increased iodide uptake and decreased glucose uptake in thyroid cancer cell line SW1736 compared to control group., Conclusion: Multiple mechanisms point to Rutin's role as a major stimulator of iodide uptake and inhibitor of glucose uptake, including effects at the mRNA and protein levels for both NIS and GLUTs, respectively. Here in, we described the flip-flop phenomenon as a possible therapeutic target for ATC. Moreover, Rutin is first documented here as a NIS expression inducer capable of restoring cell differentiation in SW1736 cell line. It also be concluded that GLUTs as metabolic targets can be blocked specifically by Rutin for thyroid cancer prevention and treatment., (© 2024. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).)
- Published
- 2024
- Full Text
- View/download PDF